Eisai Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.
The item "Net-Income" stands at 49.37 Billion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025.
Eisai Co. Ltd.'s second quarter result of 10.15 Billion JPY for the item "Net Income" represents a decrease of -29.85 percent compared to it's first quarter result.
Also, Eisai Co. Ltd.'s second quarter result of 10.15 Billion JPY for the item "Net Income" represents a decrease of -8.62 percent compared to it's second quarter result of last year.
Looking again at the trailing twelve months series (TTM), Eisai Co. Ltd.'s second quarter result of 49.37 Billion JPY for the item "Net Income" represents a decrease of -1.90 percent compared to it's first quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 20.49 percent compared to the value the year prior.
The 1 year change in percent is 20.49.
The 3 year change in percent is 53.15.
The 5 year change in percent is -59.05.
The 10 year change in percent is 12.53.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Net Income | 905,699,262,464.00 |
![]() | Johnson & Johnson - Net Income | 486,508,953,600.00 |
![]() | AbbVie Inc - Net Income | 399,570,305,024.00 |
![]() | Roche Holding AG - Net Income | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Net Income | 280,205,508,085.11 |